Emory Healthcare CEO: What to Expect from Trump's HHS Nominee
Those provisions help hospitals financially, although Georgia, notably, is not one of the states that has expanded Medicaid under the PPACA.
Lewin, who has met with Price only once, has been at the helm of Emory Healthcare for less than a year, but over the holidays, he shared his views with HealthLeaders Media on his fellow physician and controversial HHS nominee. Following is a lightly edited transcript of his answers to those questions.
HLM: In your one meeting with Dr. Price, what did you discuss with him?
Lewin: We talked about the importance of research. He expressed support for strong federal funding of scientific and biomedical research. This is an issue of significant importance across Emory, and we really appreciate his support.
The issue of economic modeling for research funding impact was discussed at length. Congressman Price expressed an interest in driving the message that research is good for the economy with his colleagues on Capitol Hill.
He asked for us to help him better communicate the research and data around this issue. As we often do for our elected officials, we completed a research memo on the topic. Further, we promised to share our own economic impact report that will be completed in spring 2017.
HLM: What was your impression of him regarding his attitude toward helping hospitals in his district?
Lewin: My impression is that Tom Price understands the importance of access to care. With his medical background, he understands how hospitals work, he recognizes the challenges facing our healthcare workforce, and he wants to do what is best for patients.